Human Microchipping Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The human microchipping market size has grown strongly in recent years. It will grow from $1.85 billion in 2024 to $1.99 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to breakthroughs in semiconductor technology and miniaturization, rising concerns about identity theft, data breaches, and unauthorized access, increasing demand for medical implants and devices, companies started exploring microchipping as a means of employee identification and access control, regulatory approval.

The human microchipping market size is expected to see strong growth in the next few years. It will grow to $2.64 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to integration with emerging technologies, increased integration of microchips with healthcare systems, growing demand for seamless and convenient payment methods, increasing adoption of microchipping technology, the development of smart city infrastructure. Major trends in the forecast period include enhanced biometric authentication, microchips embedded in wearable devices and medical implants, augmented reality integration, environmental sustainability, personalized healthcare.

The growing demand for contactless transactions is expected to propel the growth of the human microchipping market going forward. Contactless transactions refer to a safe way of making a purchase when the seller's point-of-sale (POS) terminal and the buyer's card don't have to come into direct contact. The COVID-19 pandemic significantly accelerated the adoption of contactless payments due to heightened concerns about hygiene and germ transmission. Human microchipping is used in contactless or digital payments using near-field communication (NFC) or radio-frequency identification (RFID) technology. Contactless payments can be made possible by implanting these microchips into a person's hand or other bodily part. For instance, in July 2023, according to a report shared by Finder.com, an Australia-based independent comparison website, an estimated 93% of Brits were using online banking in 2022 and another 5.3 million Brits (10%) intend to get a digital-only bank account in 2023. Further, the number of digital-only bank account holders is predicted to be 22.6 million (43%) by 2026. Therefore, the growing demand for contactless transactions is driving the growth of the human microchipping market.

Leading companies in the human microchipping market are advancing technologies like neuron spike detection to boost brain-computer interface (BCI) functionality, foster seamless human-machine communication, and improve neuroprosthetic devices for people with mobility challenges. Neuron spike detection is essential for recognizing and analyzing the electrical signals generated by neurons, advancing our understanding of brain activity and enhancing BCI performance. For example, in January 2024, Neuralink Corporation, a U.S.-based tech firm focused on BCI technology, introduced Telepathy, a human brain-computer interface. This wireless device includes a chip and over 1,000 ultra-thin, flexible electrode arrays implanted into the cerebral cortex. Telepathy detects neuronal activity related to movement, converting these neural signals into computer commands to enable thought-based communication at high speeds. Key features of Telepathy include neuron spike detection, wireless capability, a flexible electrode design for minimally invasive use, and precise robotic implantation, all designed to support enhanced communication for individuals with severe disabilities.

In December 2022, Cantaloupe Inc., a US-based technology company, acquired Three Square Market for $4 million. With this acquisition, Cantaloupe will enhance its position in the micro market industry by offering comprehensive service capabilities. Additionally, the acquisition leads to an immediate expansion of Cantaloupe's global reach, enabling the company to introduce its full range of products to new international markets. Three Square Market is a US-based provider of human microchipping and implanted microchips.

Major companies operating in the human microchipping market are Johnson Controls International PLC, Texas Instruments Inc., STMicroelectronics N.V., NXP Semiconductors, Xerox Corporation, ARM Holdings Plc, Neuralink Corporation, Kaspersky Lab, Cherry Biotech SAS, VivoKey Technologies, Avid Identification Systems Inc., EpiCenter, Micronit Microtechnologies B.V., Applied Digital Solutions, Grindhouse Wetware, Dangerous Things LLC, Digiwell, Baja Beach Club, BioTeq Ltd., Somark Innovations, Walletmor Ltd., Chip AG, Biohax International AB, VeriChip Corporation.

North America was the largest region in the human microchipping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human microchipping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the human microchipping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human microchipping market consists of revenues earned by entities by providing services such as microchip implantation, integration, data management, and research and development. The market value includes the value of related goods sold by the service provider or included within the service offering. The human microchipping market also includes sales of syringes, RFID (Radio Frequency Identification) devices, silicate glass, bio-safe encasement, and antenna wire coils. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Human microchipping refers to a process that involves the implantation of microscopic integrated circuits, typically under the skin, to serve various purposes. The utilization of human microchipping offers advantages such as seamless access to health information during emergencies, automated management of devices, and enhanced convenience in everyday activities.

The main types of human microchips are implantable microchips and non-implantable microchips. Implantable microchips refer to electronic devices that are implanted subcutaneously (under the skin) in humans or animals. Various types of technologies are included, such as RFID (radio frequency identification), NFC (near-field communication), and others. These are used for various applications, including medical identification and monitoring, personal identification and access control, financial transactions, and others, by several end users, such as healthcare, financial services, retail and logistics, government and law enforcement, and others.

The main types of human microchips are implantable microchips and non-implantable microchips. Implantable microchips refer to electronic devices that are implanted subcutaneously (under the skin) in humans or animals. Various types of technologies are included, such as RFID (radio frequency identification), NFC (near-field communication), and others. These are used for various applications, including medical identification and monitoring, personal identification and access control, financial transactions, and others, by several end users, such as healthcare, financial services, retail and logistics, government and law enforcement, and others.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.